Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
- PMID: 38992574
- DOI: 10.1016/j.lfs.2024.122899
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Abstract
This comprehensive review provides an in-depth analysis of how nanotechnology has revolutionized cancer theragnostic, which combines diagnostic and therapeutic methods to customize cancer treatment. The study examines the unique attributes, uses, and difficulties linked to different types of nanoparticles, including gold, iron oxide, silica, Quantum dots, Carbon nanotubes, and liposomes, in the context of cancer treatment. In addition, the paper examines the progression of nanotheranostics, emphasizing its uses in precise medication administration, photothermal therapy, and sophisticated diagnostic methods such as MRI, CT, and fluorescence imaging. Moreover, the article highlights the capacity of nanoparticles to improve the effectiveness of drugs, reduce the overall toxicity in the body, and open up new possibilities for treating cancer by releasing drugs in a controlled manner and targeting specific areas. Furthermore, it tackles concerns regarding the compatibility of nanoparticles and their potential harmful effects, emphasizing the significance of continuous study to improve nanotherapeutic methods for use in medical treatments. The review finishes by outlining potential future applications of nanotechnology in predictive oncology and customized medicine.
Keywords: Cancer cells; Diagnostic modalities; Drug delivery; Nanoparticles; Therapeutic functions.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Next-generation nanotheranostics targeting cancer stem cells.Nanomedicine (Lond). 2019 Sep;14(18):2487-2514. doi: 10.2217/nnm-2018-0443. Epub 2019 Sep 6. Nanomedicine (Lond). 2019. PMID: 31490100 Review.
-
Cancer nanotheranostics: Strategies, promises and impediments.Biomed Pharmacother. 2016 Dec;84:291-304. doi: 10.1016/j.biopha.2016.09.035. Epub 2016 Sep 22. Biomed Pharmacother. 2016. PMID: 27665475 Review.
-
Nanocarriers for anticancer drugs--new trends in nanomedicine.Curr Drug Metab. 2013 Jun;14(5):547-64. doi: 10.2174/1389200211314050005. Curr Drug Metab. 2013. PMID: 23687925 Review.
-
Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.J Control Release. 2016 Dec 10;243:303-322. doi: 10.1016/j.jconrel.2016.10.023. Epub 2016 Oct 26. J Control Release. 2016. PMID: 27794493 Review.
-
Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.Curr Drug Discov Technol. 2012 Dec;9(4):319-29. doi: 10.2174/157016312803305898. Curr Drug Discov Technol. 2012. PMID: 22725687 Review.
Cited by
-
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma.Cancers (Basel). 2024 Aug 27;16(17):2975. doi: 10.3390/cancers16172975. Cancers (Basel). 2024. PMID: 39272834 Free PMC article. Review.
-
Co-Amorphization, Dissolution, and Stability of Quench-Cooled Drug-Drug Coamorphous Supersaturating Delivery Systems with RT-Unstable Amorphous Components.Pharmaceutics. 2024 Nov 21;16(12):1488. doi: 10.3390/pharmaceutics16121488. Pharmaceutics. 2024. PMID: 39771470 Free PMC article.
-
Polymerase Chain Reaction Chips for Biomarker Discovery and Validation in Drug Development.Micromachines (Basel). 2025 Feb 20;16(3):243. doi: 10.3390/mi16030243. Micromachines (Basel). 2025. PMID: 40141854 Free PMC article. Review.
-
Nanomedicine for cancer patient-centered care.MedComm (2020). 2024 Oct 20;5(11):e767. doi: 10.1002/mco2.767. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39434967 Free PMC article. Review.
-
The wonders of X-PDT: an advance route to cancer theranostics.J Nanobiotechnology. 2024 Oct 25;22(1):655. doi: 10.1186/s12951-024-02931-5. J Nanobiotechnology. 2024. PMID: 39456085 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical